Welcure Drugs & Pharmaceuticals announced on Wednesday that it has finalized a contract with Thailand-based Fortune Sagar Impex Compamy for third-party sourcing and procurement services totaling Rs 517 cr
.jpeg)
India's drug exports and pharmaceuticals posted a year-on-year increase of 7.4 percent to US dollar 2.47 billion in May 2025 from US dollar 2.31 billion in the corresponding month last year, based on Ministry of Commerce and Industry released data.
Alembic Pharmaceuticals Ltd reported on Wednesday, June 18, that it has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing site, at Karakhadi, Gujarat...
.jpeg)
Syngene International shares are expected to be in focus after two major regulatory statements by the United States Food and Drug Administration (USFDA) on inspections at the company's Bengaluru-based facilities.
.jpeg)
Bayer has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for gadoquatrane, the firm's investigational gadolinium-based contrast agent for use in contrast-enhanced CNS and other body region MRI.
Boehringer Ingelheim, a global leader in animal health, has announced the launch of its latest poultry vaccine in India—a single-dose, next-generation solution that provides protection against Bursal, Newcastle and Marek’s disease...
In a significant step toward strengthening India’s pharmaceutical and trade export ecosystem, the Directorate General of Foreign Trade (DGFT), Ministry of Commerce and Industry, has announced the launch of the ‘Source from India’ feature...
The Department of Pharmaceuticals (DoP) has clarified that they extended the application period for the most recent PLI scheme round for bulk drugs, from June 14 to July 4, 2025...
Johnson & Johnson reported positive results from a Phase 2 study of the combination of Talvey (talquetamab-tgvs) and Tecvayli (teclistamab-cqyv)—both bispecific antibodies that have been...
Eli Lilly announced its acquisition of gene-editing startup Verve Therapeutics in a deal with up to a potential of $1.3 billion, expanding its pipeline, which now also features weight-loss medications and its blockbuster diabetes drugs...
, CDSCO.jpg)
